关注
Carla Treloar
Carla Treloar
在 unsw.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri, G Dusheiko, E Bugianesi, ...
The Lancet 399 (10319), 61-116, 2022
3472022
Understanding barriers to hepatitis C virus care and stigmatization from a social perspective
C Treloar, J Rance, M Backmund
Clinical Infectious Diseases 57 (suppl_2), S51-S55, 2013
2152013
Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia
A Doab, C Treloar, GJ Dore
Clinical Infectious Diseases 40 (Supplement_5), S313-S320, 2005
1982005
Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: Utility of a mixed methods approach
L Brener, W Von Hippel, C Von Hippel, I Resnick, C Treloar
Drug and Alcohol Review 29 (5), 491-497, 2010
1952010
Addiction stigma and the biopolitics of liberal modernity: A qualitative analysis
S Fraser, K Pienaar, E Dilkes-Frayne, D Moore, R Kokanovic, C Treloar, ...
International Journal of Drug Policy 44, 192-201, 2017
1922017
The social production of hepatitis C risk among injecting drug users: a qualitative synthesis
T Rhodes, C Treloar
Addiction 103 (10), 1593-1603, 2008
1542008
Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework
E Day, M Hellard, C Treloar, J Bruneau, NK Martin, A Øvrehus, O Dalgard, ...
Liver International 39 (1), 20-30, 2019
1422019
Single index of multimorbidity did not predict multiple outcomes
JE Byles, C D'Este, L Parkinson, R O'Connell, C Treloar
Journal of clinical epidemiology 58 (10), 997-1005, 2005
1422005
Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study
M Alavi, J Grebely, M Micallef, AJ Dunlop, AC Balcomb, CA Day, ...
Clinical Infectious Diseases 57 (suppl_2), S62-S69, 2013
1382013
The lived experience of hepatitis C and its treatment among injecting drug users: qualitative synthesis
C Treloar, T Rhodes
Qualitative Health Research 19 (9), 1321-1334, 2009
1282009
Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals
C Treloar, J Newland, J Rance, M Hopwood
Journal of viral hepatitis 17 (12), 839-844, 2010
1232010
Beyond deficit:‘Strengths‐based approaches’ in Indigenous health research
J Bryant, R Bolt, JR Botfield, K Martin, M Doyle, D Murphy, S Graham, ...
Sociology of health & illness 43 (6), 1405-1421, 2021
1192021
‘Spoiled identity’in hepatitis C infection: The binary logic of despair
S Fraser, C Treloar
Critical Public Health 16 (2), 99-110, 2006
1172006
Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs
C Treloar, J Rance, K Yates, L Mao
International Journal of Drug Policy 27, 138-145, 2016
1152016
“We are people too”: Consumer participation and the potential transformation of therapeutic relations within drug treatment
J Rance, C Treloar
International Journal of Drug Policy 26 (1), 30-36, 2015
1142015
Beyond interferon side effects: what residual barriers exist to DAA hepatitis C treatment for people who inject drugs?
A Madden, M Hopwood, J Neale, C Treloar
PloS one 13 (11), e0207226, 2018
1062018
Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting
J Bryant, L Brener, P Hull, C Treloar
Drug and alcohol dependence 107 (2-3), 182-187, 2010
1052010
Pleasure and drugs
M Holt, C Treloar
International Journal of Drug Policy 19 (5), 2008
1052008
Equity of access to treatment, and barriers to treatment for illicit drug use in Australia
E Digiusto, C Treloar
Addiction 102 (6), 958-969, 2007
1042007
Some characteristics of early‐onset injection drug users prior to and at the time of their first injection
J Abelson, C Treloar, J Crawford, S Kippax, I Van Beek, J Howard
Addiction 101 (4), 548-555, 2006
1022006
系统目前无法执行此操作,请稍后再试。
文章 1–20